QC
BSX icon

QCM Cayman’s Boston Scientific BSX Stock Holding History

QCM Cayman’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,222
Closed -$201K – 165
2015
Q3 		$201K Buy
+12,222
New +$209K 0.07% 182
2015
Q1 		– Sell
-25,796
Closed -$342K – 205
2014
Q4 		$342K Buy
25,796
+8,134
+46% +$104K 0.14% 110
2014
Q3 		$209K Buy
+17,662
New +$222K 0.05% 166

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

QCM Cayman's BSX Position: Q4 2015 in Review

QCM Cayman sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 12,222 shares — an estimated $201K sold.

QCM Cayman first reported a position in BSX in Q3 2014 and held it in 3 quarters. The position peaked at $342K in Q4 2014. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

  • QCM Cayman reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
  • QCM Cayman sold 12,222 Boston Scientific shares in Q4 2015, an estimated $201K.
  • QCM Cayman first reported a position in Boston Scientific in Q3 2014 and held it in 3 quarters.
  • QCM Cayman's Boston Scientific position peaked at $342K in Q4 2014.
  • 502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on QCM Cayman's 13F filing for Q4 2015, filed 16 Feb 2016.